Operator
Welcome to the LeMaitre Vascular’s Q1 2026 Financial Results Conference Call. As a reminder to everyone, today’s call is being recorded.
At this time, I would like to turn the call over to Mr. Dorian LeBlanc, Chief Financial Officer of LeMaitre Vascular. Please go ahead, sir.
Dorian LeBlanc
Chief Financial Officer
Thank you. Good afternoon, and thank you for joining us on our Q1 2026 conference call. With me on today’s call is our CEO, George LeMaitre; and our President, Dave Roberts.
Before we begin, I’ll read our safe harbor statement. Today, we’ll be making some forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, the accuracy of which is subject to risks and uncertainties. Wherever possible, we will try to identify those forward-looking statements by using words such as believe, expect, anticipate, pursue, forecast and similar expressions. Our forward-looking statements are based on our estimates and assumptions as of today, May 5, 2026, and should not be relied upon as representing our estimates or views on any subsequent date. Please refer to the Cautionary Statement regarding forward-looking information and the Risk Factors in our most recent 10-K and subsequent SEC filings, including disclosures of factors that could cause results to differ materially from those expressed or implied. During this call, we will discuss non-GAAP financial measures, such as organic sales growth. Reconciliations of GAAP to non-GAAP measures discussed
